Stay updated on TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a minor update to the page content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s software/display revision indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change rather than an update to the clinical trial study details.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check75 days agoChange DetectedFooter now displays Revision: v3.4.3; the previous Revision: v3.4.2 label is no longer displayed.SummaryDifference0.1%

- Check96 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the Study Documents section.SummaryDifference0.1%

Stay in the know with updates to TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.